About neoSurgical
neoSurgical is a company based in Galway (Ireland) founded in 2008 was acquired by Sharp Fluidics in April 2020.. neoSurgical has raised $13.26 million across 3 funding rounds from investors including Enterprise Ireland, Sharp Fluidics and Targeted Technology. neoSurgical operates in a competitive market with competitors including Olympus, Eximis Surgical, SurgiQuest, New View Surgical and Xenocor, among others.
- Headquarter Galway, Ireland
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neosurgical Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.26 M (USD)
in 3 rounds
-
Latest Funding Round
$5.5 M (USD), Series B
Jun 06, 2017
-
Investors
Enterprise Ireland
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Sharp Fluidics
(Apr 07, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of neoSurgical
neoSurgical has successfully raised a total of $13.26M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $5.5 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $5.5M
-
First Round
First Round
(22 Sep 2011)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Series B - neoSurgical | Valuation |
investors |
|
| Apr, 2015 | Amount | Series B - neoSurgical | Valuation |
investors |
|
| Sep, 2011 | Amount | Series A - neoSurgical | Valuation | Kernel Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in neoSurgical
neoSurgical has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, Sharp Fluidics and Targeted Technology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage investments in medical and life science technologies are made by Targeted Technology.
|
Founded Year | Domain | Location | |
|
VC firm investing in the UK and the US
|
Founded Year | Domain | Location | |
|
Support is provided to Irish manufacturing and service sector businesses.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by neoSurgical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - neoSurgical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neosurgical Comparisons
Competitors of neoSurgical
neoSurgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, Eximis Surgical, SurgiQuest, New View Surgical and Xenocor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of imaging and surgical products
|
|
| domain | founded_year | HQ Location |
Minimal invasive specimen removal tools
|
|
| domain | founded_year | HQ Location |
Products for minimally invasive surgery are developed and supplied.
|
|
| domain | founded_year | HQ Location |
Minimally invasive systems for laparoscopic surgery are developed.
|
|
| domain | founded_year | HQ Location |
Laparoscopic imaging systems for surgical applications are provided.
|
|
| domain | founded_year | HQ Location |
Patented laparoscopic instruments are designed, manufactured, and distributed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Neosurgical
Frequently Asked Questions about neoSurgical
When was neoSurgical founded?
neoSurgical was founded in 2008 and raised its 1st funding round 3 years after it was founded.
Where is neoSurgical located?
neoSurgical is headquartered in Galway, Ireland.
Is neoSurgical a funded company?
neoSurgical is a funded company, having raised a total of $13.26M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2.16M, raised on Sep 22, 2011.
What does neoSurgical do?
neoSurgical was founded in 2008 in Galway, Ireland, as a provider of medical devices in the surgical sector. Laparoscopic instruments are developed and supplied, with the lead product neoClose utilized for port site closure after abdominal procedures. Additional devices support access and retraction during laparoscopic surgeries. Operations focus on instrument innovation for minimally invasive techniques in healthcare settings.
Who are the top competitors of neoSurgical?
neoSurgical's top competitors include Olympus, New View Surgical and SurgiQuest.
Who are neoSurgical's investors?
neoSurgical has 4 investors. Key investors include Enterprise Ireland, Sharp Fluidics, Targeted Technology, and Kernel Capital.
What is neoSurgical's valuation?
The valuation of neoSurgical is $21M as of Apr 2015.